Results 211 to 220 of about 38,348 (306)

Galectin-3: a novel biomarker of glycogen storage disease type III. [PDF]

Cell Death Discov
Rossiaud L, Miagoux Q, Benabides M, Reiss O, Jauze L, Jarrige M, Polvèche H, Malfatti E, Laforêt P, Ronzitti G, Nissan X, Hoch L.   +11 more
europepmc   +1 more source

Serendipitous compound action potential oscillations reveal glycolytic astrocyte and oxidative axon interstitial K+ buffering in central white matter

Experimental Physiology, EarlyView.
Abstract The principal processes that govern interstitial K+ ([K+]o) buffering in mouse optic nerve (MON), a central white matter tract, either directly consume energy (Na+–K+‐ATPase) or use transmembrane ion gradients created by energy‐dependent pumps to enable the K+ fluxes that maintain a stable [K+]o, and thus ready availability of utilisable ...
Amy J. Hopper, Angus M. Brown
wiley   +1 more source

Comparative effects of a glucose–fructose bar, glucose–fructose hydrogel and maltodextrin gel on carbohydrate oxidation and sprint performance in Tier 2 athletes

Experimental Physiology, EarlyView.
Abstract Carbohydrate supplementation optimises athletic performance, but the metabolic and performance impacts of commercial products/compositions are underexplored. We compared the efficacy of three commercial carbohydrate supplements: a glucose–fructose bar (GF‐Bar), a glucose–fructose hydrogel (GF‐Gel) and a maltodextrin‐based gel (MD‐Gel ...
Ewan Dean, Ash Osborne, Daren Subar, Paul Hendrickse, Christopher J. Gaffney   +4 more
wiley   +1 more source

Infant Born With Autosomal Recessive Glycogen Storage Disease Type IV due to Complete Maternal Isodisomy of Chromosome 3. [PDF]

Case Rep Genet
Olsen SS, Ernst A, Christensen PS, Björnsdóttir ED, Mark LR, Stefansen AV, Højland AT.   +6 more
europepmc   +1 more source

Induced Pluripotent Stem Cells and CRISPR-Cas9 Innovations for Treating Alpha-1 Antitrypsin Deficiency and Glycogen Storage Diseases [PDF]

Colin Walsh, Sha Jin
openalex   +1 more source

Identification of a Pathogenic Mutation for Glycogen Storage Disease Type II (Pompe Disease) in Japanese Quails (<i>Coturnix japonica</i>). [PDF]

Genes (Basel)
Faruq AA, Matsui T, Maki S, Arakawa N, Watanabe K, Kobayashi Y, Rakib TM, Islam MS, Yabuki A, Yamato O.   +9 more
europepmc   +1 more source

Infantile Onset Glycogen Storage Disease Type 2: Case Report

, 2014
Serkan Bilge Koca, Emine Polat, Bahtisen Bayram, Gizem Ürel, Saliha Şenel, İlyas Okur   +5 more
openalex   +1 more source

The efficacy and physiological bases of small muscle mass exercise in health and disease

Experimental Physiology, EarlyView.
Abstract The conventional approach to aerobic exercise prescription involves large muscle mass exercise and the manipulation of variables such as training intensity, duration and frequency to promote desired adaptations. However, during whole‐body exercise, central limitations (i.e., neural, pulmonary and/or cardiac) constrain exercise tolerance and ...
Callum G. Brownstein
wiley   +1 more source

The Management and Clinical Outcomes of Pregnancy in a Female With Glycogen Storage Disease Type IIIA Caused by Rare Variant. [PDF]

JIMD Rep
Puente-Ruiz N, Palaniappan S, Woodall A, Cooper R, Terry A, Oldham A, Rousseau A, Campbell C, Vasudevan P, Stepien KM.   +9 more
europepmc   +1 more source

A Rare Case of Glycogen Storage Disease Type IIIa with a Novel Homozygous AGL Splice Variant in a Two-Year-Old Female born out of Consanguineous Marriage [PDF]

Rajashree Ratnaparkhe
openalex   +1 more source